Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 29 Nov 2022

3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction

in Molecular and Cellular Oncology

Huan Zhang
Huanyao Gao
Yayun Gu
August John
Lixuan Wei
Minhong Huang
Jia Yu
Adeyemi A. Adeosun
Richard M. Weinshilboum
Liewei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.999302

5,047 views
9 citations

Review

Published on 29 Nov 2022

Pyroptosis: A new insight of non-small-cell lung cancer treatment

in Molecular and Cellular Oncology

Xi Chen
Jianzhang Wu
Jiabing Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1013544

4,201 views
9 citations

Original Research

Published on 29 Nov 2022

Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation

in Molecular and Cellular Oncology

Bo Chen
Tianjiao Mao
Xiuni Qin
Wenqi Zhang
Nobumoto Watanabe
Jiang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1029998

3,203 views
5 citations

Original Research

Published on 24 Nov 2022

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma

in Molecular and Cellular Oncology

Tao Liu
Lubing Gu
Zhongzhi Wu
Najah Albadari
Wei Li
Muxiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1058726

2,685 views
1 citation

Review

Published on 24 Nov 2022

The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review

in Molecular and Cellular Oncology

April A. Apfelbaum
Emma D. Wrenn
Elizabeth R. Lawlor

Frontiers in Oncology

doi 10.3389/fonc.2022.1044707

10,170 views
33 citations

Review

Published on 24 Nov 2022

Tumor microbiome – an integral part of the tumor microenvironment

in Molecular and Cellular Oncology

Sona Ciernikova
Aneta Sevcikova
Viola Stevurkova
Michal Mego

Frontiers in Oncology

doi 10.3389/fonc.2022.1063100

16,243 views
50 citations

Original Research

Published on 24 Nov 2022

FCGR3A: A new biomarker with potential prognostic value for prostate cancer

in Molecular and Cellular Oncology

Zeyu Zha
Yuan Hong
ZhenFeng Tang
Qiuling Du
Yan Wang
Shengbang Yang
Yongding Wu
Huijing Tan
Funneng Jiang
Weide Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.1014888

3,467 views
5 citations

Mini Review

Published on 23 Nov 2022

SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion/metastasis

in Molecular and Cellular Oncology

Salma M. S. Ahmad
Maryam Al-Mansoob
Allal Ouhtit

Frontiers in Oncology

doi 10.3389/fonc.2022.1038121

3,558 views
2 citations

Original Research

Published on 23 Nov 2022

Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer

in Molecular and Cellular Oncology

Ratna Priya
Vaishali Jain
Javed Akhtar
Neeraj Saklani
Puja Sakhuja
Anil Kumar Agarwal
Ravindra Varma Polisetty
Ravi Sirdeshmukh
Sudeshna Kar
Poonam Gautam

Frontiers in Oncology

doi 10.3389/fonc.2022.1027914

3,148 views
6 citations

Original Research

Published on 23 Nov 2022

HLA-BAT1 alters migration, invasion and pro-inflammatory cytokines in prostate cancer

in Molecular and Cellular Oncology

Aileen M. García-Vargas
Yarelis M. Roque-Reyes
Desiree M. Arroyo-Villegas
Daniel Santiago-Negron
María M. Sánchez-Vázquez
Alejandro Rivera-Torres
Andrea C. Reyes-Meléndez
Valerie Cardona-Berdecía
Miosotis García-Maldonado
Olga M. Víquez

Frontiers in Oncology

doi 10.3389/fonc.2022.969396

2,182 views

Original Research

Published on 21 Nov 2022

MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer

in Molecular and Cellular Oncology

Jun Zhou
Ming Xu
Jie Tan
Lin Zhou
Fang Dong
Tao Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1030590

4,263 views
8 citations

Review

Published on 21 Nov 2022

The role of CXCR3 and its ligands in cancer

in Molecular and Cellular Oncology

Xiaoming Wang
Yangyang Zhang
Sen Wang
Hongyan Ni
Peng Zhao
Guangyu Chen
Benling Xu
Long Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.1022688

15,451 views
73 citations

Review

Published on 21 Nov 2022

Hallmarks of cancer: The insulin-like growth factors perspective

in Molecular and Cellular Oncology

Haim Werner
Derek LeRoith

Frontiers in Oncology

doi 10.3389/fonc.2022.1055589

7,216 views
22 citations

Original Research

Published on 17 Nov 2022

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma

in Molecular and Cellular Oncology

Laure Hervé
Stefano Kim
Jihane Boustani
Elodie Klajer
Mandy Pernot
Thierry Nguyen
Zaher Lakkis
Christophe Borg
Angélique Vienot

Frontiers in Oncology

doi 10.3389/fonc.2022.974108

4,049 views
1 citation

Review

Published on 17 Nov 2022

Insulin-like growth factor binding protein 5: Diverse roles in cancer

in Molecular and Cellular Oncology

Jennifer A. Waters
Ixchel Urbano
Mikella Robinson
Carrie D. House

Frontiers in Oncology

doi 10.3389/fonc.2022.1052457

7,534 views
29 citations

Original Research

Published on 17 Nov 2022

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma

in Molecular and Cellular Oncology

Xiaoshan Hu
Liyi Guo
Guihong Liu
Zili Dai
Li Wang
Jian Zhang
Jun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.997702

4,226 views
6 citations